Kristin T Mills

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

Kayvon Modjarrad, Christine C. Roberts, Kristin T Mills et al. · The Lancet Infectious Diseases · 2019 · 314 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Kayvon Modjarrad, Leyi Lin, Sarah L. George et al. · The Lancet · 2017 · 193 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +7

A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular Electroporation

Jay W. Hooper, Kristopher Paolino, Kristin T Mills et al. · Vaccines · 2020 · 36 citations · Full text

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population

Michele Spring, Jason Sousa, Qigui Li et al. · The Journal of Infectious Diseases · 2019 · 29 citations · Full text

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial

Michael Koren, Leyi Lin, Kenneth H. Eckels et al. · The Lancet Infectious Diseases · 2023 · 21 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7